InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by ZUMWALT LEANNE M, Director. Director active across 1 company, notably Akebia Therapeutics, Inc.. Cumulatively, 4 reports have been logged. Activity tracked since 8 June 2022. The latest transaction was disclosed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Leanne M. Zumwalt is a Director at Akebia Therapeutics, Inc. She contributes to corporate governance and the strategic direction of the company. As a board member, she participates in important decision-making and oversight of Akebia's operations. Her experience in the biopharmaceutical sector is an asset for the company.